Editorial: in the era of effective antiviral therapy, long‐term dynamic endoscopic monitoring does not seem to be necessary for all CHB patients with compensated cirrhosis

LINKED CONTENT This article is linked to Farina et al paper. To view this article, visit https://doi.org/10.1111/apt.17463

Saved in:
Bibliographic Details
Published in:Alimentary pharmacology & therapeutics 2023-06, Vol.57 (12), p.1467-1468
Main Authors: Li, Lan‐Qing, Chen, En‐Qiang
Format: Article
Language:English
Subjects:
Antiviral agents
Antiviral Agents - therapeutic use
Cirrhosis
Humans
Liver Cirrhosis - diagnosis
Liver Cirrhosis - drug therapy
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:LINKED CONTENT This article is linked to Farina et al paper. To view this article, visit https://doi.org/10.1111/apt.17463
ISSN:0269-2813
1365-2036
DOI:10.1111/apt.17487